Verdinexor

CAS: 1392136-43-4

Ref. 3D-FV175276

Produktinformation

• Name: Verdinexor

Beschreibung

Verdinexor is an antibody-based therapeutic that targets the fatty acid binding protein (FABP) receptor, which is expressed at high levels in cancer cells. It has been shown to inhibit the proliferation of cervical cancer cells and induce apoptosis. Verdinexor also binds to epidermal growth factor and prevents its interaction with the FABP receptor. This drug has minimal toxicity and can be administered intravenously or subcutaneously, making it a promising therapeutic for patients with hematopoietic cancers.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 442.32 g/mol
• Formel: C₁₈H₁₂F₆N₆O
• Reinheit: Min. 95%
• InChl: InChI=1S/C18H12F6N6O/c19-17(20,21)12-7-11(8-13(9-12)18(22,23)24)16-26-10-30(29-16)6-4-15(31)28-27-14-3-1-2-5-25-14/h1-10H,(H,25,27)(H,28,31)/b6-4-
• InChI Key: InChIKey=OPAKEJZFFCECPN-XQRVVYSFSA-N
• SMILES: O=C(/C=C\n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)NNc1ccccn1